PIIIW — P3 Health Partners Inc.

PIIIW Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Membership: Approximately 116,000 members, consistent with expectations.
• Capitated Revenue: $341.6 million, translating to about $982 per member per month (PMPM).
• Adjusted EBITDA: Loss of $45.9 million for the quarter; year-to-date loss of $85.2 million. Normalized adjusted EBITDA loss for the year is approximately $70 million.
• Medical Margin: $4.4 million for the quarter ($13 PMPM), up from $500,000 ($1 PMPM) in the prior year. Year-to-date medical margin was $52.2 million ($50 PMPM), normalized to $80.8 million ($78 PMPM).
• Operating Expenses: Reduced to $21.1 million from $31.6 million year-over-year, reflecting a 33% improvement.

2. Strategic Updates and Business Highlights:

• The company is in a transitional year focused on stability, operational discipline, and clinical foundation maturity.
• Capitated revenue increased by 6%, with normalized medical cost trends remaining flat year-over-year.
• A strategic joint venture is expected to add approximately 13,000 fully accretive ACO members, enhancing profitability and cash flow.
• The company is rationalizing its provider network to improve margins, exiting non-aligned groups and focusing on high-performing Tier 1 providers.

3. Forward Guidance and Outlook:

• Full-year adjusted EBITDA guidance revised to a loss range of $110 million to $95 million, reflecting current performance expectations.
• The company anticipates $120 million to $170 million in EBITDA expansion opportunities for 2026, driven by improved alignment with population burden, scaling clinical programs, and contractual improvements.
• Positive macro trends are expected to support a more sustainable benefit design and improved rate environment.

4. Bad News, Challenges, or Points of Concern:

• The quarter experienced a $24 million unfavorable impact due to midyear settlements and prior period adjustments, indicating ongoing visibility issues with claims.
• The guidance reduction was attributed to broader issues rather than a single payor or market, with some headwinds still present from non-core assets.
• There are concerns about the potential for future prior period adjustments and the need for improved data visibility from payors.

5. Notable Q&A Insights:

• Management emphasized the importance of aligning incentives with payors to ensure accountability in medical management.
• There is an ongoing effort to improve communication and expectations with payors to mitigate past issues with prior period adjustments.
• The company expects a 5% net improvement in premiums due to favorable MA rates, with additional coding improvements anticipated to further enhance revenue.
• Future guidance on the impact of coding improvements will be provided in subsequent quarters, but management is optimistic about gross margin expansion in 2026 if current trends continue.

Overall, while PIIIW is facing challenges, particularly related to visibility and prior period adjustments, it is taking strategic steps to stabilize and improve its operational foundation, positioning itself for profitability in 2026.